Tumor Copy Number Deconvolution Integrating Bulk and Single-Cell Sequencing Data

Characterizing intratumor heterogeneity (ITH) is crucial to understanding cancer development, but it is hampered by limits of available data sources. Bulk DNA sequencing is the most common technology to assess ITH, but mixes many genetically distinct cells in each sample, which must then be computationally deconvolved. Single-cell sequencing (SCS) is a promising alternative, but its limitations — e.g., high noise, difficulty scaling to large populations, technical artifacts, and large data sets — have so far made it impractical for studying cohorts of sufficient size to identify statistically robust features of tumor evolution. We have developed strategies for deconvolution and tumor phylogenetics combining limited amounts of bulk and single-cell data to gain some advantages of single-cell resolution with much lower cost, with specific focus on deconvolving genomic copy number data. We developed a mixed membership model for clonal deconvolution via non-negative matrix factorization (NMF) balancing deconvolution quality with similarity to single-cell samples via an associated efficient coordinate descent algorithm. We then improve on that algorithm by integrating deconvolution with clonal phylogeny inference, using a mixed integer linear programming (MILP) model to incorporate a minimum evolution phylogenetic tree cost in the problem objective. We demonstrate the effectiveness of these methods on semi-simulated data of known ground truth, showing improved deconvolution accuracy relative to bulk data alone.

[1]  L. Pusztai,et al.  Cancer heterogeneity: implications for targeted therapeutics , 2013, British Journal of Cancer.

[2]  Oliver Hofmann,et al.  Copy-number signatures and mutational processes in ovarian carcinoma , 2017, Nature Genetics.

[3]  Florian Markowetz,et al.  OncoNEM: inferring tumor evolution from single-cell sequencing data , 2016, Genome Biology.

[4]  N. Navin,et al.  Clonal Evolution in Breast Cancer Revealed by Single Nucleus Genome Sequencing , 2014, Nature.

[5]  Ron Shamir,et al.  Complexity and algorithms for copy-number evolution problems , 2017, Algorithms for Molecular Biology.

[6]  Russell Schwartz,et al.  Robust unmixing of tumor states in array comparative genomic hybridization data , 2010, Bioinform..

[7]  Shankar Vembu,et al.  PhyloWGS: Reconstructing subclonal composition and evolution from whole-genome sequencing of tumors , 2015, Genome Biology.

[8]  A. Schäffer,et al.  Tumorigenesis and Neoplastic Progression Single-Cell Genetic Analysis of Ductal Carcinoma in Situ and Invasive Breast Cancer Reveals Enormous Tumor Heterogeneity yet Conserved Genomic Imbalances and Gain of MYC during Progression , 2012 .

[9]  Benjamin J. Raphael,et al.  Inferring the Mutational History of a Tumor Using Multi-state Perfect Phylogeny Mixtures. , 2016, Cell systems.

[10]  Russell Schwartz,et al.  Applying unmixing to gene expression data for tumor phylogeny inference , 2010, BMC Bioinformatics.

[11]  A. Jemal,et al.  Colorectal cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.

[12]  Christian Bauckhage,et al.  Convex Non-negative Matrix Factorization in the Wild , 2009, 2009 Ninth IEEE International Conference on Data Mining.

[13]  Evis Sala,et al.  Spatial and Temporal Heterogeneity in High-Grade Serous Ovarian Cancer: A Phylogenetic Analysis , 2015, PLoS medicine.

[14]  Xun Zhu,et al.  Using single-cell multiple omics approaches to resolve tumor heterogeneity , 2017, Clinical and Translational Medicine.

[15]  S. Morrison,et al.  Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution , 2009, Cell.

[16]  Russell Schwartz,et al.  Inferring models of multiscale copy number evolution for single-tumor phylogenetics , 2015, Bioinform..

[17]  Angela E. Leek,et al.  Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution , 2017, Cell.

[18]  S. Gabriel,et al.  Pan-cancer patterns of somatic copy-number alteration , 2013, Nature Genetics.

[19]  R. Schwartz,et al.  Reference-free inference of tumor phylogenies from single-cell sequencing data , 2014, 2014 IEEE 4th International Conference on Computational Advances in Bio and Medical Sciences (ICCABS).

[20]  Liqin Xu,et al.  Diverse evolutionary dynamics in glioblastoma inference by multi-region and single-cell sequencing. , 2016 .

[21]  Russell Schwartz,et al.  Algorithms to Model Single Gene, Single Chromosome, and Whole Genome Copy Number Changes Jointly in Tumor Phylogenetics , 2014, PLoS Comput. Biol..

[22]  Michael W. Berry,et al.  Algorithms and applications for approximate nonnegative matrix factorization , 2007, Comput. Stat. Data Anal..

[23]  L. Loeb,et al.  A mutator phenotype in cancer. , 2001, Cancer research.

[24]  K. Polyak,et al.  Tumor heterogeneity: causes and consequences. , 2010, Biochimica et biophysica acta.

[25]  Marc J. Williams,et al.  Identification of neutral tumor evolution across cancer types , 2016, Nature Genetics.

[26]  Yu-Jin Zhang,et al.  Nonnegative Matrix Factorization: A Comprehensive Review , 2013, IEEE Transactions on Knowledge and Data Engineering.

[27]  Matthew N Davies,et al.  Dissecting cancer evolution at the macro-heterogeneity and micro-heterogeneity scale , 2015, Current opinion in genetics & development.

[28]  J. Troge,et al.  Tumour evolution inferred by single-cell sequencing , 2011, Nature.

[29]  Ken Chen,et al.  SiFit: inferring tumor trees from single-cell sequencing data under finite-sites models , 2017, Genome Biology.

[30]  Samuel Aparicio,et al.  Scalable whole-genome single-cell library preparation without preamplification , 2017, Nature Methods.

[31]  N. Beerenwinkel,et al.  Advances in understanding tumour evolution through single-cell sequencing* , 2017, Biochimica et biophysica acta. Reviews on cancer.

[32]  Sijia Lu,et al.  Single-Cell Whole-Genome Amplification and Sequencing: Methodology and Applications. , 2015, Annual review of genomics and human genetics.

[33]  Faraz Hach,et al.  PhISCS: a combinatorial approach for subperfect tumor phylogeny reconstruction via integrative use of single-cell and bulk sequencing data , 2018, Genome Research.

[34]  Michael Wigler,et al.  Genome-wide copy number analysis of single cells , 2012, Nature Protocols.

[35]  A. Chen,et al.  Defining precision: The precision medicine initiative trials NCI-MPACT and NCI-MATCH. , 2017, Current problems in cancer.

[36]  Jack Kuipers,et al.  Integrative inference of subclonal tumour evolution from single-cell and bulk sequencing data , 2017, Nature Communications.

[37]  H. Sebastian Seung,et al.  Algorithms for Non-negative Matrix Factorization , 2000, NIPS.

[38]  Guy E. Blelloch,et al.  Efficiently Finding the Most Parsimonious Phylogenetic Tree Via Linear Programming , 2007, ISBRA.

[39]  Benjamin J. Raphael,et al.  Phylogenetic Copy-Number Factorization of Multiple Tumor Samples , 2018, J. Comput. Biol..

[40]  D. Dexter,et al.  Tumor heterogeneity and drug resistance. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  Nancy R. Zhang,et al.  Assessing intratumor heterogeneity and tracking longitudinal and spatial clonal evolutionary history by next-generation sequencing , 2016, Proceedings of the National Academy of Sciences.

[42]  A. Schäffer,et al.  The evolution of tumour phylogenetics: principles and practice , 2017, Nature Reviews Genetics.

[43]  Huanming Yang,et al.  Single-Cell Exome Sequencing and Monoclonal Evolution of a JAK2-Negative Myeloproliferative Neoplasm , 2012, Cell.

[44]  Russell Schwartz,et al.  Deconvolution and phylogeny inference of structural variations in tumor genomic samples , 2018, bioRxiv.

[45]  P. Nowell The clonal evolution of tumor cell populations. , 1976, Science.